{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:52:02Z","timestamp":1757587922278},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1992,6,1]],"date-time":"1992-06-01T00:00:00Z","timestamp":707356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutisch Weekblad Scientific Edition"],"published-print":{"date-parts":[[1992,6]]},"DOI":"10.1007\/bf01962703","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T05:10:48Z","timestamp":1122613848000},"page":"127-131","source":"Crossref","is-referenced-by-count":9,"title":["Effects of valproate on xenobiotic biotransformation in rat liver"],"prefix":"10.1007","volume":"14","author":[{"given":"V.","family":"Rogiers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Callaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vercruysse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Akrawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Shephard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01962703_CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03259935","volume":"3","author":"MJ Eadi","year":"1988","unstructured":"Eadi MJ, Hooper WD, Dickinson RG. Valproate associated hepatotoxicity and its biochemical mechanisms. Med Toxicol 1988;3:85\u2013106.","journal-title":"Med Toxicol"},{"key":"BF01962703_CR2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/clinchem\/34.5.890","volume":"34","author":"D Cotariu","year":"1988","unstructured":"Cotariu D, Zaidman JL. Valproic acid and the liver. Clin Chem 1988;34:890\u20137.","journal-title":"Clin Chem"},{"key":"BF01962703_CR3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.37.3.379","volume":"37","author":"FE Dreifuss","year":"1987","unstructured":"Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA. Valproic acid hepatic fatalities; a retrospective review. Neurology 1987;37:379\u201385.","journal-title":"Neurology"},{"key":"BF01962703_CR4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1528-1157.1988.tb03757.x","volume":"29","author":"D Scheffner","year":"1988","unstructured":"Scheffner D, K\u00f6nig S, Rauterberg-Ruland I, Kochen W, Hofmann WJ, Unkelbach S. Fatal liver failure in 16 children with valproate therapy. Epilepsia 1988;29: 530\u201342.","journal-title":"Epilepsia"},{"key":"BF01962703_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2008-1059589","volume":"13","author":"FA Wolff De","year":"1982","unstructured":"De Wolff FA, Peters ACB, Kempen GMJ. Serum concentrations and enzyme induction in epileptic children with phenytoin and valproate. Neuropediatrics 1982; 13:10\u20133.","journal-title":"Neuropediatrics"},{"key":"BF01962703_CR6","first-page":"196","volume":"21","author":"E J\u00e4ger","year":"1980","unstructured":"J\u00e4ger E, Rating D, Platzek T, Helge H. Induction of drug metabolism by antiepileptic drugs. Epilepsia 1980;21:196.","journal-title":"Epilepsia"},{"key":"BF01962703_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2125.1979.tb05821.x","volume":"8","author":"J Oxley","year":"1979","unstructured":"Oxley J, Hedges A, Makki KA, Monks A, Richens A. Lack of hepatic enzyme inducing effect of sodium valproate. Br J Clin Pharmacol 1979;8:189\u201390.","journal-title":"Br J Clin Pharmacol"},{"key":"BF01962703_CR8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1984.tb02482.x","volume":"18","author":"E Perucca","year":"1984","unstructured":"Perucca E, Hedges A, Makki KA, Ruprah M, Wilson JF, Richens A. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. Br J Clin Pharmacol 1984;18:401\u201310.","journal-title":"Br J Clin Pharmacol"},{"key":"BF01962703_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.1988.tb05274.x","volume":"26","author":"PN Patsalos","year":"1988","unstructured":"Patsalos PN, Duncan JS, Shorvon SD. Effect of the removal of individual antiepileptic drugs on antipyrine kinetics in patients taking polytherapy. Br J Clin Pharmacol 1988;26:253\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"BF01962703_CR10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.30.6.588","volume":"30","author":"HL Bonkowsky","year":"1980","unstructured":"Bonkowsky HL, Sinclair PR, Emery S, Sinclair JF. Seizure management in acute hepatic porphyria: risks of valproate and clonazepam. Neurology 1980;30:588\u201392.","journal-title":"Neurology"},{"key":"BF01962703_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0197-0186(86)90098-7","volume":"8","author":"GF Carl","year":"1986","unstructured":"Carl GF, De Loach C, Patterson J. Chronic sodium valproate treatment in the rat: toxicity versus protection against seizures induced by Indoclon. Neurochemistry, 1986;8:41\u20135.","journal-title":"Neurochemistry"},{"key":"BF01962703_CR12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000469385","volume":"34","author":"D Cotariu","year":"1985","unstructured":"Cotariu D, Evans S, Zaidman JL. Effect of sodium valproate on subcellular fraction enzymes in rat liver. Enzyme 1985;34:196\u2013200.","journal-title":"Enzyme"},{"key":"BF01962703_CR13","unstructured":"Dickens M, Parsons DN. The effect of lamotrigine, a novel anticonvulsant upon hepatic drug metabolising enzyme systems in the rat and the marmoset [abstract]. In: Proceedings of the International Symposium on Clinical and Basic Aspects of Enzyme Induction and Inhibition; 1985 Jul 5\u20136; Essen, 1985:35."},{"key":"BF01962703_CR14","first-page":"112","volume-title":"Clinical and pharmacological aspects of sodium valproate in the treatment of epilepsy","author":"BJ Jordan","year":"1984","unstructured":"Jordan BJ, Shillingford JS, Steed KP. Preliminary observations on the protein binding and enzyme inducing properties of sodium valproate. In: Legg NJ, ed. Clinical and pharmacological aspects of sodium valproate in the treatment of epilepsy. London: MCS Consultants, 1984:112."},{"key":"BF01962703_CR15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840040609","volume":"4","author":"JW Kesterson","year":"1984","unstructured":"Kesterson JW, Granneman GR, Machinist JM. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology 1984;4:1143\u201352.","journal-title":"Hepatology"},{"key":"BF01962703_CR16","first-page":"767","volume":"10","author":"N Sapeika","year":"1975","unstructured":"Sapeika N, Kaplan ER. Effect of the anti-epileptic drug sodium valproate on induction of hepatic microsomal P-450. Res Commun Chem Pathol Pharmacol 1975;10: 767\u20139.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"BF01962703_CR17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/00498258809041705","volume":"18","author":"V Rogiers","year":"1988","unstructured":"Rogiers V, Vandenberghe Y, Callaerts A, Sonck W, Maes V, Vercruysse A. The inducing and inhibiting effects of sodium valproatein vivo on the biotransformation systems of xenobiotics in isolated hepatocytes. Xenobiotica 1988;18:665\u201373.","journal-title":"Xenobiotica"},{"key":"BF01962703_CR18","first-page":"75","volume-title":"The liver, metabolism and ageing","author":"V Rogiers","year":"1988","unstructured":"Rogiers V, Vandenberghe Y, Cornet M, Callaerts A, Sonck W, Guillourd A, et al. The use of cultures and cocultures of rat hepatocytes for the study of the effects of valproate on phase I and II biotransformation systems of xenobiotics. In: Woodhouse KW, Yelland C, James OFW, eds. The liver, metabolism and ageing. Amsterdam: Elsevier Biomedical Press, 1988:75\u201382."},{"key":"BF01962703_CR19","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/0006-2952(90)90345-L","volume":"40","author":"V Rogiers","year":"1990","unstructured":"Rogiers V, Vandenberghe Y, Callaerts A, Verleye G, Hertens K, Cornet M, et al. Phase I and phase II xenobiotics biotransformation in cultures and co-cultures of adult rat hepatocytes. Biochem Pharmacol 1990;40: 1701\u20136.","journal-title":"Biochem Pharmacol"},{"key":"BF01962703_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0378-1119(83)90034-3","volume":"24","author":"IR Phillips","year":"1983","unstructured":"Phillips IR, Shephard EA, Ashworth A, Rabin BR. Cloning and sequence analysis of a rat liver cDNA coding for a phenobarbital-inducible microheterogeneous cytochrome P-450 variant: regulation of its messenger level by xenobiotics. Gene 1983;24:41\u201352.","journal-title":"Gene"},{"key":"BF01962703_CR21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/dna.1983.2.329","volume":"2","author":"G Cathala","year":"1983","unstructured":"Cathala G, Savouret J-F, Mendez B, West BL, Karin M, Martial JA, et al. A method for isolation of intact, transcriptionally active ribonucleic acid. DNA 1983;2:329\u201334.","journal-title":"DNA"},{"key":"BF01962703_CR22","first-page":"5","volume":"10","author":"RM Fourney","year":"1988","unstructured":"Fourney RM, Miyakoshi J, Day RS, Paterson MC. Northern blotting efficient RNA staining and transfer. BRL Focus 1988;10:5\u20136.","journal-title":"BRL Focus"},{"key":"BF01962703_CR23","first-page":"583","volume":"211","author":"RG Dickinson","year":"1979","unstructured":"Dickinson RG, Harland RC, Elias AM. Disposition of valproic acid in the rat, dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. J Pharmacol Exp Ther 1979;211:583\u201395.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF01962703_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-2952(85)90111-X","volume":"34","author":"G Heinemeyer","year":"1985","unstructured":"Heinemeyer G, Nau H, Hildebrandt AG, Roots I. Oxidation and glucuronidation of valproic acid in male rats. Influence of phenobarbital, 3-methylcholantrene, B-naphtoflavone and clofibrate. Biochem Pharmacol 1985;34:133\u20139.","journal-title":"Biochem Pharmacol"},{"key":"BF01962703_CR25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-4827(83)90107-6","volume":"143","author":"C Guguen-Guillouzo","year":"1983","unstructured":"Guguen-Guillouzo C, Clement B, Baffet G, Beaumont C, Morel-Chany E, Glaise D, et al. Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type. Exp Cell Res 1983;143:47\u201354.","journal-title":"Exp Cell Res"},{"key":"BF01962703_CR26","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0006-2952(83)90341-6","volume":"32","author":"JM B\u00e9gu\u00e9","year":"1984","unstructured":"B\u00e9gu\u00e9 JM, Le Bigot JF, Guguen-Guillouzo A, Kiechel JR, Guillouzo A. Cultured human adult hepatocytes; a new model for drug metabolism studies. Biochem Pharmacol 1984;32:1643\u20136.","journal-title":"Biochem Pharmacol"},{"key":"BF01962703_CR27","first-page":"313","volume-title":"Isolated and cultured hepatocytes","author":"A Guillouzo","year":"1986","unstructured":"Guillouzo A. Use of isolated and cultured hepatocytes for xenobiotic metabolism and cytotoxicity studies. In: Guillouzo A, Guguen-Guillouzo C, eds. Isolated and cultured hepatocytes. Paris: Les \u00c9ditions Inserm John Libbey Eurotext, 1986:313."},{"key":"BF01962703_CR28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0006-2952(84)90425-8","volume":"33","author":"AM Edwards","year":"1984","unstructured":"Edwards AM, Glistak ML, Lucas CM, Wilson PA. 7-Ethoxycoumarin deethylase activity as a convenient measure of liver drug metabolizing enzymes: regulation in cultured rat hepatocytes. Biochem Pharmacol 1984;33:1537\u201346.","journal-title":"Biochem Pharmacol"},{"key":"BF01962703_CR29","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/0006-2952(87)90535-1","volume":"36","author":"T Wolff","year":"1987","unstructured":"Wolff T, Guengerich FP. Rat liver cytochrome P-450 isoenzymes as catalysts of aldrin epoxidation in reconstituted monoxygenase systems and microsomes. Biochem Pharmacol 1987;36:2581\u20138.","journal-title":"Biochem Pharmacol"}],"container-title":["Pharmaceutisch Weekblad Scientific Edition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01962703.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01962703\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01962703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T11:56:08Z","timestamp":1586346968000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01962703"}},"subtitle":["In vivo andin vitro experiments"],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1992,6]]}},"alternative-id":["BF01962703"],"URL":"https:\/\/doi.org\/10.1007\/bf01962703","relation":{},"ISSN":["0167-6555","1573-739X"],"issn-type":[{"value":"0167-6555","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,6]]}}}